Mechanisms of protection of hepatocytes at anoxia and reoxygenation by the xanthine oxidase inhibitor oxypurinol.
Schneider
W
W
Institute of Biochemistry, Medical School Charité, Humboldt University, Berlin, Germany.
Siems
W G
WG
Grune
T
T
Schneider
C
C
Gerber
G
G
D000227:Adenine Nucleotides / Q000378:metabolism; D000241:Adenosine / Q000378:metabolism*; D000244:Adenosine Diphosphate / Q000378:metabolism; D000249:Adenosine Monophosphate / Q000378:metabolism; D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D015687:Cell Hypoxia; D002478:Cells, Cultured; D019271:Hypoxanthine; D007042:Hypoxanthines / Q000378:metabolism*; D007291:Inosine Monophosphate / Q000378:metabolism*; D007700:Kinetics; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D010100:Oxygen / Q000494:pharmacology; D010117:Oxypurinol / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D013997:Time Factors; D014969:Xanthine Oxidase / Q000037:antagonists & inhibitors*
D000227:Adenine Nucleotides; D007042:Hypoxanthines; D007291:Inosine Monophosphate; D019271:Hypoxanthine; D000249:Adenosine Monophosphate; D000244:Adenosine Diphosphate; D000255:Adenosine Triphosphate; D014969:Xanthine Oxidase; D010117:Oxypurinol; D000241:Adenosine; D010100:Oxygen